422 related articles for article (PubMed ID: 30068240)
1. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.
Schaub SK; Hartvigson PE; Lock MI; Høyer M; Brunner TB; Cardenes HR; Dawson LA; Kim EY; Mayr NA; Lo SS; Apisarnthanarax S
Technol Cancer Res Treat; 2018 Jan; 17():1533033818790217. PubMed ID: 30068240
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
Soni PD; Palta M
Dig Dis Sci; 2019 Apr; 64(4):1008-1015. PubMed ID: 30868409
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
Choi SH; Seong J
Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
[TBL] [Abstract][Full Text] [Related]
4. Role of stereotactic body radiation therapy for hepatocellular carcinoma.
Sanuki N; Takeda A; Kunieda E
World J Gastroenterol; 2014 Mar; 20(12):3100-11. PubMed ID: 24696597
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment.
Kellock T; Liang T; Harris A; Schellenberg D; Ma R; Ho S; Yap WW
Br J Radiol; 2018 May; 91(1085):20170118. PubMed ID: 29334232
[TBL] [Abstract][Full Text] [Related]
6. Advances in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
Murray LJ; Dawson LA
Semin Radiat Oncol; 2017 Jul; 27(3):247-255. PubMed ID: 28577832
[TBL] [Abstract][Full Text] [Related]
7. Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma.
Jung J; Yoon SM; Cho B; Choi YE; Kwak J; Kim SY; Lee SW; Ahn SD; Choi EK; Kim JH
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):96-101. PubMed ID: 26503671
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
McPartlin AJ; Dawson LA
Cancer J; 2016; 22(4):296-301. PubMed ID: 27441750
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium.
Shanker MD; Liu HY; Lee YY; Stuart KA; Powell EE; Wigg A; Pryor DI
J Gastroenterol Hepatol; 2021 Apr; 36(4):873-884. PubMed ID: 32632941
[TBL] [Abstract][Full Text] [Related]
10. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy.
Moon DH; Wang AZ; Tepper JE
Radiother Oncol; 2018 Mar; 126(3):527-533. PubMed ID: 29366521
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities.
Meyer J; Singal AG
Liver Transpl; 2018 Mar; 24(3):420-427. PubMed ID: 29205797
[TBL] [Abstract][Full Text] [Related]
13. Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma.
Chen YX; Zhuang Y; Yang P; Fan J; Zhou J; Hu Y; Zhu WC; Sun J; Zeng ZC
Technol Cancer Res Treat; 2020; 19():1533033820937002. PubMed ID: 32613904
[TBL] [Abstract][Full Text] [Related]
14. Dose-function Histogram Evaluation Using
Toya R; Saito T; Shiraishi S; Kai Y; Murakami R; Matsuyama T; Watakabe T; Sakamoto F; Tsuda N; Shimohigashi Y; Yamashita Y; Oya N
Anticancer Res; 2018 Mar; 38(3):1511-1516. PubMed ID: 29491079
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
Doi H; Beppu N; Kitajima K; Kuribayashi K
Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
[TBL] [Abstract][Full Text] [Related]
16. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls.
Mastrocostas K; Jang HJ; Fischer S; Dawson LA; Munoz-Schuffenegger P; Sapisochin G; Kim TK
Abdom Radiol (NY); 2019 May; 44(5):1795-1807. PubMed ID: 30710166
[TBL] [Abstract][Full Text] [Related]
17. An overview of stereotactic body radiation therapy for hepatocellular carcinoma.
Kimura T; Doi Y; Takahashi S; Kubo K; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Murakami Y; Kenjo M; Nagata Y
Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):271-279. PubMed ID: 32223683
[No Abstract] [Full Text] [Related]
18. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer.
Toesca DAS; Osmundson EC; von Eyben R; Shaffer JL; Koong AC; Chang DT
Pract Radiat Oncol; 2017; 7(3):173-182. PubMed ID: 28343896
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
Moore A; Cohen-Naftaly M; Tobar A; Kundel Y; Benjaminov O; Braun M; Issachar A; Mor E; Sarfaty M; Bragilovski D; Hur RB; Gordon N; Stemmer SM; Allen AM
Radiat Oncol; 2017 Oct; 12(1):163. PubMed ID: 29052532
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
Velec M; Haddad CR; Craig T; Wang L; Lindsay P; Brierley J; Brade A; Ringash J; Wong R; Kim J; Dawson LA
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):939-946. PubMed ID: 28333016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
